Connection

GARABED EKNOYAN to Humans

This is a "connection" page, showing publications GARABED EKNOYAN has written about Humans.
Connection Strength

1.083
  1. Phosphorus: Chronicles of the epistemology of a vital element. Clin Nephrol. 2024 Sep; 102(3):117-124.
    View in: PubMed
    Score: 0.024
  2. Cardiorenal Syndrome: An Evolutionary Appraisal. Circ Heart Fail. 2024 Jun; 17(6):e011510.
    View in: PubMed
    Score: 0.023
  3. Transplant nephropathology: Wherefrom, wherein, and whereto. Clin Transplant. 2024 04; 38(4):e15309.
    View in: PubMed
    Score: 0.023
  4. Interstitial Nephritis: Wherefrom, Wherein, and Whereto. Exp Clin Transplant. 2023 06; 21(Suppl 2):42-45.
    View in: PubMed
    Score: 0.022
  5. Acid-base homeostasis: a historical inquiry of its origins and conceptual evolution. Nephrol Dial Transplant. 2022 09 22; 37(10):1816-1823.
    View in: PubMed
    Score: 0.021
  6. On the evolution of the language of nephrology. Nephrol Dial Transplant. 2021 07 23; 36(8):1361-1365.
    View in: PubMed
    Score: 0.019
  7. Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution. Kidney Int. 2021 06; 99(6):1321-1330.
    View in: PubMed
    Score: 0.019
  8. On the Etymology of Nephritis: A Historical Appraisal of its Origins. J Am Soc Nephrol. 2020 06; 31(6):1170-1173.
    View in: PubMed
    Score: 0.018
  9. A historical perspective of how public policy shaped dialysis care delivery in the United States. Semin Dial. 2020 01; 33(1):5-9.
    View in: PubMed
    Score: 0.017
  10. Lupus nephritis: A historical appraisal of how?a?skin lesion became a kidney disease?. Clin Nephrol. 2019 Jun; 91(6):325-333.
    View in: PubMed
    Score: 0.017
  11. Pyelonephritis: A Historical Reappraisal. J Am Soc Nephrol. 2019 06; 30(6):914-917.
    View in: PubMed
    Score: 0.017
  12. Uremia: A historical reappraisal of what happened?. Clin Nephrol. 2018 May; 89(5):305-313.
    View in: PubMed
    Score: 0.015
  13. A History of Uremia Research. J Ren Nutr. 2017 11; 27(6):449-452.
    View in: PubMed
    Score: 0.015
  14. The kidney in sickle hemoglobinopathies?. Clin Nephrol. 2017 Feb; 87 (2017)(2):55-68.
    View in: PubMed
    Score: 0.014
  15. Nephrology: As It Was Then, But Is Not Now. Am J Kidney Dis. 2017 Jan; 69(1):129-135.
    View in: PubMed
    Score: 0.014
  16. Stephen Hales: the contributions of an Enlightenment physiologist to the study of the kidney in health and disease. G Ital Nefrol. 2016 Feb; 33 Suppl 66:33.S66.5.
    View in: PubMed
    Score: 0.013
  17. Beginnings-The Kidney and Nephrology in Ancient Mesopotamian Culture. Semin Dial. 2016 05; 29(3):236-46.
    View in: PubMed
    Score: 0.013
  18. A forgotten chapter in the history of the renal circulation: the Josep Trueta and Homer Smith intellectual conflict. Am J Physiol Renal Physiol. 2015 Jul 15; 309(2):F90-7.
    View in: PubMed
    Score: 0.013
  19. Herbal diuretics in medieval Persian and Arabic medicine. J Altern Complement Med. 2015 Jun; 21(6):309-20.
    View in: PubMed
    Score: 0.013
  20. The Scientific Revolution--The Kidney and Nephrology in and about the Seventeenth Century (Part 1). Semin Dial. 2015 May-Jun; 28(3):282-92.
    View in: PubMed
    Score: 0.012
  21. Clinical trials in uremia-time to reappraise. J Ren Nutr. 2015 Mar; 25(2):250-5.
    View in: PubMed
    Score: 0.012
  22. Acute interstitial nephritis - a reappraisal and update. Clin Nephrol. 2014 Sep; 82(3):149-62.
    View in: PubMed
    Score: 0.012
  23. The early modern kidney--nephrology in and about the nineteenth century (part 2). Semin Dial. 2014 Sep-Oct; 27(5):494-503.
    View in: PubMed
    Score: 0.012
  24. Tubulointerstitial nephritis and cancer chemotherapy: update on a neglected clinical entity. Nephrol Dial Transplant. 2013 Oct; 28(10):2502-9.
    View in: PubMed
    Score: 0.011
  25. Women: medicine, their kidneys, and nephrology. Adv Chronic Kidney Dis. 2013 Sep; 20(5):382-9.
    View in: PubMed
    Score: 0.011
  26. Music, musicians, medicine, and the kidney. Semin Dial. 2014 Jan-Feb; 27(1):50-6.
    View in: PubMed
    Score: 0.011
  27. The early modern kidney--nephrology in and about the nineteenth century. Part 1. Semin Dial. 2013 Jan-Feb; 26(1):73-84.
    View in: PubMed
    Score: 0.011
  28. A decade after the KDOQI CKD guidelines: a historical perspective. Am J Kidney Dis. 2012 Nov; 60(5):686-8.
    View in: PubMed
    Score: 0.011
  29. The late medieval kidney--nephrology in and about the fourteenth century. Semin Dial. 2012 Sep-Oct; 25(5):550-9.
    View in: PubMed
    Score: 0.010
  30. Discourse on pulse in medieval Persia--the Hidayat of Al-Akhawayni (?-983 A D.). Int J Cardiol. 2013 Jun 20; 166(2):289-93.
    View in: PubMed
    Score: 0.010
  31. The Renaissance Kidney-Nephrology in and about the Sixteenth Century. Semin Dial. 2012 Jul; 25(4):451-9.
    View in: PubMed
    Score: 0.010
  32. The enlightenment kidney-nephrology in and about the eighteenth century. Semin Dial. 2012 Jan-Feb; 25(1):74-81.
    View in: PubMed
    Score: 0.010
  33. Erich Frank (1884-1957): unsung pioneer in nephrology. Am J Kidney Dis. 2011 Oct; 58(4):654-65.
    View in: PubMed
    Score: 0.010
  34. Obesity and chronic kidney disease. Nefrologia. 2011; 31(4):397-403.
    View in: PubMed
    Score: 0.010
  35. On the usefulness of the history of nephrology. J Nephrol. 2011 May-Jun; 24 Suppl 17:S1-3.
    View in: PubMed
    Score: 0.009
  36. Obstructive uropathy. Contrib Nephrol. 2011; 169:311-326.
    View in: PubMed
    Score: 0.009
  37. A history of diabetes insipidus: paving the road to internal water balance. Am J Kidney Dis. 2010 Dec; 56(6):1175-83.
    View in: PubMed
    Score: 0.009
  38. Why we need clinical practice guidelines in chronic kidney disease. J Ren Nutr. 2010 Sep; 20(5 Suppl):S127-30.
    View in: PubMed
    Score: 0.009
  39. History of Nephrology: a process confronted with changing times and of those who practiced it. J Nephrol. 2009 Nov-Dec; 22 Suppl 14:1-2.
    View in: PubMed
    Score: 0.009
  40. Armenian medicine and diseases of the kidney. J Nephrol. 2009 Nov-Dec; 22 Suppl 14:3-7.
    View in: PubMed
    Score: 0.009
  41. The wonderful apparatus of John Jacob Abel called the "artificial kidney". Semin Dial. 2009 May-Jun; 22(3):287-96.
    View in: PubMed
    Score: 0.008
  42. Chronic kidney disease definition and classification: no need for a rush to judgment. Kidney Int. 2009 May; 75(10):1015-8.
    View in: PubMed
    Score: 0.008
  43. Salivary phosphorus binding: a novel approach to control hyperphosphatemia. J Am Soc Nephrol. 2009 Mar; 20(3):460-2.
    View in: PubMed
    Score: 0.008
  44. Global nephrology guidelines: a first small step in the right direction. Nephrol Dial Transplant. 2009 Mar; 24(3):728-30.
    View in: PubMed
    Score: 0.008
  45. Progress and promise in the management of chronic kidney disease. CMAJ. 2008 Nov 18; 179(11):1107-8.
    View in: PubMed
    Score: 0.008
  46. Are global nephrology guidelines feasible? Nat Clin Pract Nephrol. 2008 Oct; 4(10):521.
    View in: PubMed
    Score: 0.008
  47. A clinical view of simple and complex renal cysts. J Am Soc Nephrol. 2009 Sep; 20(9):1874-6.
    View in: PubMed
    Score: 0.008
  48. The artificial kidney: past, present, and future. Minerva Chir. 2008 Aug; 63(4):293-9.
    View in: PubMed
    Score: 0.008
  49. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2008 Nov; 74(10):1237-40.
    View in: PubMed
    Score: 0.008
  50. Emergence of the concept of acute kidney injury. Adv Chronic Kidney Dis. 2008 Jul; 15(3):308-13.
    View in: PubMed
    Score: 0.008
  51. Artificial kidneys: progress and promise. Lancet. 2007 Dec 15; 370(9604):1977-8.
    View in: PubMed
    Score: 0.008
  52. Obesity, diabetes, and chronic kidney disease. Curr Diab Rep. 2007 Dec; 7(6):449-53.
    View in: PubMed
    Score: 0.007
  53. Chronic kidney disease definition and classification: the quest for refinements. Kidney Int. 2007 Nov; 72(10):1183-5.
    View in: PubMed
    Score: 0.007
  54. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 Aug; 72(3):247-59.
    View in: PubMed
    Score: 0.007
  55. Looking at the urine: the renaissance of an unbroken tradition. Am J Kidney Dis. 2007 Jun; 49(6):865-72.
    View in: PubMed
    Score: 0.007
  56. The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int. 2007 May; 71(10):1054-61.
    View in: PubMed
    Score: 0.007
  57. Kidney disease: wherefore, whence, and whereto? Kidney Int. 2007 Mar; 71(6):473-5.
    View in: PubMed
    Score: 0.007
  58. A history of obesity, or how what was good became ugly and then bad. Adv Chronic Kidney Dis. 2006 Oct; 13(4):421-7.
    View in: PubMed
    Score: 0.007
  59. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006 Dec; 70(12):2058-65.
    View in: PubMed
    Score: 0.007
  60. A history of diabetes mellitus -- a disease of the kidneys that became a kidney disease. J Nephrol. 2006 May-Jun; 19 Suppl 10:S71-4.
    View in: PubMed
    Score: 0.007
  61. On the origin of genetics and beginnings of medical genetics of diseases of the kidney. Adv Chronic Kidney Dis. 2006 Apr; 13(2):174-7.
    View in: PubMed
    Score: 0.007
  62. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006 Feb; 17(2):546-55.
    View in: PubMed
    Score: 0.007
  63. The kidneys in the Bible: what happened? J Am Soc Nephrol. 2005 Dec; 16(12):3464-71.
    View in: PubMed
    Score: 0.006
  64. On the evolution of pediatrics and the emergence of pediatric nephrology. Adv Chronic Kidney Dis. 2005 Oct; 12(4):406-11.
    View in: PubMed
    Score: 0.006
  65. Alternative medicine: the renaissance of an unbroken tradition. Adv Chronic Kidney Dis. 2005 Jul; 12(3):247-50.
    View in: PubMed
    Score: 0.006
  66. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 Jun; 67(6):2089-100.
    View in: PubMed
    Score: 0.006
  67. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv Chronic Kidney Dis. 2005 Apr; 12(2):223-9.
    View in: PubMed
    Score: 0.006
  68. Introduction: Adequacy of dialysis: problems and challenges. Semin Nephrol. 2005 Mar; 25(2):67-9.
    View in: PubMed
    Score: 0.006
  69. Emergence of quantification in clinical investigation and the quest for certainty in therapeutics: the road from Hammurabi to Kefauver. Adv Chronic Kidney Dis. 2005 Jan; 12(1):88-95.
    View in: PubMed
    Score: 0.006
  70. The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis. 2004 Nov; 44(5 Suppl 2):1-6.
    View in: PubMed
    Score: 0.006
  71. The burden of kidney disease: improving global outcomes. Kidney Int. 2004 Oct; 66(4):1310-4.
    View in: PubMed
    Score: 0.006
  72. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. Am Fam Physician. 2004 Sep 15; 70(6):1091-7.
    View in: PubMed
    Score: 0.006
  73. Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician. 2004 Sep 01; 70(5):869-76.
    View in: PubMed
    Score: 0.006
  74. On the central role of studies on the kidney in the recognition, conceptual evolution, and understanding of hypertension. Adv Chronic Kidney Dis. 2004 Apr; 11(2):192-6.
    View in: PubMed
    Score: 0.006
  75. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol. 2003 Dec; 14(12):3251-63.
    View in: PubMed
    Score: 0.006
  76. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis. 2003 Oct; 42(4):617-22.
    View in: PubMed
    Score: 0.006
  77. Francis Delafield (1841-1915): the original contributions of an American investigator to diseases of the kidney. J Nephrol. 2003 Sep-Oct; 16(5):779-84.
    View in: PubMed
    Score: 0.006
  78. Meeting the challenges of the new K/DOQI guidelines. Am J Kidney Dis. 2003 Jun; 41(5 Suppl):3-10.
    View in: PubMed
    Score: 0.005
  79. On testing for proteinuria: time for a methodical approach. Cleve Clin J Med. 2003 Jun; 70(6):493, 496-7, 501.
    View in: PubMed
    Score: 0.005
  80. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference. Am J Kidney Dis. 2003 Apr; 41(4):868-76.
    View in: PubMed
    Score: 0.005
  81. On the evolving nature of understanding dialysis-related disorders. Am J Kidney Dis. 2003 Apr; 41(4 Suppl 4):S1-3.
    View in: PubMed
    Score: 0.005
  82. The Armenian earthquake of 1988: a milestone in the evolution of nephrology. Adv Ren Replace Ther. 2003 Apr; 10(2):87-92.
    View in: PubMed
    Score: 0.005
  83. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19; 347(25):2010-9.
    View in: PubMed
    Score: 0.005
  84. Emergence of the concept of acute renal failure. Am J Nephrol. 2002 Jul; 22(2-3):225-30.
    View in: PubMed
    Score: 0.005
  85. Rufus of Ephesus and his "Diseases of the Kidneys". Nephron. 2002 Jul; 91(3):383-90.
    View in: PubMed
    Score: 0.005
  86. On improving outcomes and quality of dialysis care, and more. Am J Kidney Dis. 2002 Apr; 39(4):889-91.
    View in: PubMed
    Score: 0.005
  87. Impact of the new K/DOQI guidelines. Blood Purif. 2002; 20(1):103-8.
    View in: PubMed
    Score: 0.005
  88. The national epidemic of chronic kidney disease. What we know and what we can do. Postgrad Med. 2001 Sep; 110(3):23-9: quiz 8.
    View in: PubMed
    Score: 0.005
  89. NKF and RPA collaborating on clinical practice guidelines for chronic kidney disease. Nephrol News Issues. 2001 Jul; 15(8):13, 54.
    View in: PubMed
    Score: 0.005
  90. Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 2001 Jan; 37(1):179-194.
    View in: PubMed
    Score: 0.005
  91. NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. Am J Kidney Dis. 2001 Jan; 37(1 Suppl 1):S5-6.
    View in: PubMed
    Score: 0.005
  92. The importance of early treatment of the anaemia of chronic kidney disease. Nephrol Dial Transplant. 2001; 16 Suppl 5:45-9.
    View in: PubMed
    Score: 0.005
  93. Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials. 2000 Oct; 21(5):502-25.
    View in: PubMed
    Score: 0.005
  94. The dialysis outcomes quality initiative: history, impact, and prospects. Am J Kidney Dis. 2000 Apr; 35(4 Suppl 1):S69-75.
    View in: PubMed
    Score: 0.004
  95. Michelangelo: art, anatomy, and the kidney. Kidney Int. 2000 Mar; 57(3):1190-201.
    View in: PubMed
    Score: 0.004
  96. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999 May; 33(5):1004-10.
    View in: PubMed
    Score: 0.004
  97. Implementation of NKF-DOQI: a progress report. Nephrol News Issues. 1999 May; 13(5):11-5, 43.
    View in: PubMed
    Score: 0.004
  98. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant. 1999 Apr; 14(4):828-33.
    View in: PubMed
    Score: 0.004
  99. Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis. 1999 Jan; 33(1):142-9.
    View in: PubMed
    Score: 0.004
  100. An overview of the National Kidney Foundation-Dialysis Outcomes Quality Initiative Implementation. Adv Ren Replace Ther. 1999 Jan; 6(1):3-6.
    View in: PubMed
    Score: 0.004
  101. Cardiovascular mortality and morbidity in dialysis patients. Miner Electrolyte Metab. 1999 Jan-Apr; 25(1-2):100-4.
    View in: PubMed
    Score: 0.004
  102. The kidney in ancient Egyptian medicine: where does it stand? Am J Nephrol. 1999; 19(2):140-7.
    View in: PubMed
    Score: 0.004
  103. Santorio Sanctorius (1561-1636) - founding father of metabolic balance studies. Am J Nephrol. 1999; 19(2):226-33.
    View in: PubMed
    Score: 0.004
  104. On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes. Am J Kidney Dis. 1998 Nov; 32(5 Suppl 3):S1-4.
    View in: PubMed
    Score: 0.004
  105. Does the choice of renal replacement therapy adversely affect the hypercoagulability associated with renal disease? Am J Nephrol. 1998; 18(3):175-8.
    View in: PubMed
    Score: 0.004
  106. The National Kidney Foundation Dialysis Outcomes Quality Initiative. Curr Opin Nephrol Hypertens. 1997 Nov; 6(6):520-3.
    View in: PubMed
    Score: 0.004
  107. Realdo Colombo (1516-1559). A reappraisal. Am J Nephrol. 1997; 17(3-4):261-8.
    View in: PubMed
    Score: 0.004
  108. Dose and adequacy. Perit Dial Int. 1997; 17 Suppl 3:S40-1.
    View in: PubMed
    Score: 0.004
  109. Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment. Drugs Aging. 1996 Nov; 9(5):341-51.
    View in: PubMed
    Score: 0.003
  110. Historical note. On the contributions of Paracelsus to nephrology. Nephrol Dial Transplant. 1996 Jul; 11(7):1388-94.
    View in: PubMed
    Score: 0.003
  111. Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. Am J Kidney Dis. 1996 Feb; 27(2):279-83.
    View in: PubMed
    Score: 0.003
  112. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996 Jan; 27(1):162-5.
    View in: PubMed
    Score: 0.003
  113. Shaul G. Massry: a man of the world and a scholar for all seasons. Am J Kidney Dis. 1995 Nov; 26(5):797-800.
    View in: PubMed
    Score: 0.003
  114. A history of the parathyroid glands. Am J Kidney Dis. 1995 Nov; 26(5):801-7.
    View in: PubMed
    Score: 0.003
  115. Votive offerings of the kidney. Am J Nephrol. 1995; 15(5):453-4.
    View in: PubMed
    Score: 0.003
  116. Current status of chronic analgesic and nonsteroidal anti-inflammatory drug nephropathy. Curr Opin Nephrol Hypertens. 1994 Mar; 3(2):182-8.
    View in: PubMed
    Score: 0.003
  117. Arabic medicine and nephrology. Am J Nephrol. 1994; 14(4-6):270-8.
    View in: PubMed
    Score: 0.003
  118. Renal malacoplakia reappraised. Am J Kidney Dis. 1993 Aug; 22(2):243-52.
    View in: PubMed
    Score: 0.003
  119. On the renal ailments of creators and leaders. Am J Kidney Dis. 1993 Jun; 21(6):653-8.
    View in: PubMed
    Score: 0.003
  120. Evolving spectrum of HIV-associated nephropathy. Nephron Clin Pract. 2012; 121(3-4):c131-5.
    View in: PubMed
    Score: 0.003
  121. Origins of nephrology: the 17th century. I. The fallacies deriving from examination of the urine according to James Primrose. Am J Nephrol. 1992; 12(1-2):94-101.
    View in: PubMed
    Score: 0.002
  122. Acute renal failure in the Armenian earthquake. Ren Fail. 1992; 14(3):241-4.
    View in: PubMed
    Score: 0.002
  123. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol. 2012 Jan; 7(1):123-30.
    View in: PubMed
    Score: 0.002
  124. ?-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study. Am J Kidney Dis. 2011 Dec; 58(6):939-45.
    View in: PubMed
    Score: 0.002
  125. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011 Nov; 80(10):1080-91.
    View in: PubMed
    Score: 0.002
  126. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. Nephrol Dial Transplant. 2012 Feb; 27(2):640-6.
    View in: PubMed
    Score: 0.002
  127. Renal consequences of antihypertensive therapy. Semin Nephrol. 1991 Mar; 11(2):129-37.
    View in: PubMed
    Score: 0.002
  128. The role of phosphate in the potentiation or amelioration of acute renal failure. Miner Electrolyte Metab. 1991; 17(2):112-5.
    View in: PubMed
    Score: 0.002
  129. Chronic tubulo-interstitial nephritis: correlation between structural and functional findings. Kidney Int. 1990 Oct; 38(4):736-43.
    View in: PubMed
    Score: 0.002
  130. Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010 Apr; 77(7):624-9.
    View in: PubMed
    Score: 0.002
  131. The origins of nephrology--Galen, the founding father of experimental renal physiology. Am J Nephrol. 1989; 9(1):66-82.
    View in: PubMed
    Score: 0.002
  132. The natural history of primary pyelonephritis. Contrib Nephrol. 1989; 75:82-9.
    View in: PubMed
    Score: 0.002
  133. Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2008 Sep; 52(3):531-40.
    View in: PubMed
    Score: 0.002
  134. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Jan; 3(1):69-77.
    View in: PubMed
    Score: 0.002
  135. Anatomy of the cranial nerves in medieval Persian literature: Esmail Jorjani (AD 1042-1137) and The treasure of the Khwarazm shah. Neurosurgery. 2007 Dec; 61(6):1325-30; discussion 1330-1.
    View in: PubMed
    Score: 0.002
  136. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007 Nov; 17(6):372-80.
    View in: PubMed
    Score: 0.002
  137. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007 Jan; 14(1):3-12.
    View in: PubMed
    Score: 0.002
  138. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006 Jun; 69(11):1945-53.
    View in: PubMed
    Score: 0.002
  139. Chronic renal failure. The primary care physician's role. Postgrad Med. 1986 May 01; 79(6):221-6, 228-30.
    View in: PubMed
    Score: 0.002
  140. Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2006 Apr; 47(4):614-24.
    View in: PubMed
    Score: 0.002
  141. Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2006 Mar; 1(2):246-55.
    View in: PubMed
    Score: 0.002
  142. Renal involvement in patients with thrombotic thrombocytopenic purpura. Am J Nephrol. 1986; 6(2):117-31.
    View in: PubMed
    Score: 0.002
  143. Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J Am Soc Nephrol. 2005 Nov; 16(11):3371-80.
    View in: PubMed
    Score: 0.002
  144. Renal vascular phenomena in systemic sclerosis (scleroderma). Semin Nephrol. 1985 Mar; 5(1):34-45.
    View in: PubMed
    Score: 0.002
  145. A new initiative in nephrology: 'Kidney disease: improving global outcomes'. Contrib Nephrol. 2005; 149:90-99.
    View in: PubMed
    Score: 0.002
  146. Renal complications of bacterial endocarditis. Am J Nephrol. 1985; 5(6):457-69.
    View in: PubMed
    Score: 0.002
  147. The HEMO Study: applicability and generalizability. Nephrol Dial Transplant. 2005 Feb; 20(2):278-84.
    View in: PubMed
    Score: 0.002
  148. Side effects of hemodialysis. N Engl J Med. 1984 Oct 04; 311(14):915-7.
    View in: PubMed
    Score: 0.002
  149. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int. 1984 Apr; 25(4):591-8.
    View in: PubMed
    Score: 0.001
  150. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int. 2004 Apr; 65(4):1386-94.
    View in: PubMed
    Score: 0.001
  151. Hypertension in older people. Compr Ther. 1983 Dec; 9(12):57-64.
    View in: PubMed
    Score: 0.001
  152. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003 Jul 15; 139(2):137-47.
    View in: PubMed
    Score: 0.001
  153. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003 Jun; 111(6 Pt 1):1416-21.
    View in: PubMed
    Score: 0.001
  154. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003 Jan; 41(1):1-12.
    View in: PubMed
    Score: 0.001
  155. Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol. 2002 Nov; 13(11):2811-2; author reply 2812-6.
    View in: PubMed
    Score: 0.001
  156. Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol. 2002 Sep; 13(9):2345-52.
    View in: PubMed
    Score: 0.001
  157. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982 Mar; 142(3):517-20.
    View in: PubMed
    Score: 0.001
  158. Renal papillary necrosis: an update. Medicine (Baltimore). 1982 Mar; 61(2):55-73.
    View in: PubMed
    Score: 0.001
  159. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol. 1981; 1(1):17-23.
    View in: PubMed
    Score: 0.001
  160. Nephrotic syndrome developing after bee stings. South Med J. 1981 Jan; 74(1):82-3.
    View in: PubMed
    Score: 0.001
  161. Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implications. Am J Kidney Dis. 2000 Jul; 36(1):1-11.
    View in: PubMed
    Score: 0.001
  162. Toxic nephropathy during continuous rifampin therapy. South Med J. 1980 Jun; 73(6):791-2.
    View in: PubMed
    Score: 0.001
  163. Acute renal failure associated with indomethacin administration. South Med J. 1980 May; 73(5):587-9.
    View in: PubMed
    Score: 0.001
  164. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer. Medicine (Baltimore). 1979 Jan; 58(1):65-79.
    View in: PubMed
    Score: 0.001
  165. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998 Nov; 32(5):853-906.
    View in: PubMed
    Score: 0.001
  166. Renal complications of infectious diseases. Med Clin North Am. 1978 Sep; 62(5):979-1003.
    View in: PubMed
    Score: 0.001
  167. Minocycline and doxycycline kinetics in chronic renal failure. Clin Pharmacol Ther. 1978 Aug; 24(2):233-9.
    View in: PubMed
    Score: 0.001
  168. Care for hypertensives in a neighborhood clinic and a hospital outpatient department: a comparison. J Ambul Care Manage. 1978 Apr; 1(2):41-51.
    View in: PubMed
    Score: 0.001
  169. Electrolyte excretion in polycystic kidney disease: interrelationship between sodium, calcium, magnesium, and phosphate. J Lab Clin Med. 1977 Dec; 90(6):1066-75.
    View in: PubMed
    Score: 0.001
  170. Assessment of structure and function in progressive renal disease. Kidney Int Suppl. 1997 Dec; 63:S144-50.
    View in: PubMed
    Score: 0.001
  171. National Kidney Foundation: Dialysis Outcome Quality Initiative--development of methodology for clinical practice guidelines. Nephrol Dial Transplant. 1997 Oct; 12(10):2060-3.
    View in: PubMed
    Score: 0.001
  172. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. II. Nephrotoxins of significant frequency and economic impact. Ren Fail. 1997 Jul; 19(4):523-34.
    View in: PubMed
    Score: 0.001
  173. Renal localization of antiglobulins in glomerulonephritis and after renal transplantation. Arthritis Rheum. 1977 May; 20(4):947-61.
    View in: PubMed
    Score: 0.001
  174. The kidney and infections. Contrib Nephrol. 1977; 7:272-89.
    View in: PubMed
    Score: 0.001
  175. Renal complications of drug addiction. Urology. 1976 Dec; 8(6):526-31.
    View in: PubMed
    Score: 0.001
  176. Soluble immune complexes in sera of patients with nephritis. Kidney Int. 1976 Sep; 10(3):256-63.
    View in: PubMed
    Score: 0.001
  177. Systemic consequences of acid-base disorders. Compr Ther. 1976 Aug; 2(8):23-6.
    View in: PubMed
    Score: 0.001
  178. Use of cardioactive drugs in acute myocardial infarction. Heart Lung. 1976 Jan-Feb; 5(1):44-61.
    View in: PubMed
    Score: 0.001
  179. Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG. J Clin Invest. 1975 Aug; 56(2):427-37.
    View in: PubMed
    Score: 0.001
  180. Malignant hypertension. Recovery of kidney function after renal allograft failure. Arch Intern Med. 1975 Feb; 135(2):300-3.
    View in: PubMed
    Score: 0.001
  181. Nephropathy in patients with drug addiction. Evolution of pathological and clinical features. Virchows Arch A Pathol Anat Histol. 1975; 365(1):1-13.
    View in: PubMed
    Score: 0.001
  182. The acute renal failure syndrome. Tex Med. 1974 Dec; 70(12):83-90.
    View in: PubMed
    Score: 0.001
  183. Letter: Renal disorders in hepatic failure. Br Med J. 1974 Jun 22; 2(5920):670.
    View in: PubMed
    Score: 0.001
  184. Codices on the art of medicine in the Montecassino Archives. Am J Nephrol. 1994; 14(4-6):488-92.
    View in: PubMed
    Score: 0.001
  185. Renal involvement in drug abuse. Arch Intern Med. 1973 Dec; 132(6):801-6.
    View in: PubMed
    Score: 0.001
  186. International dialysis aid in earthquakes and other disasters. Kidney Int. 1993 Sep; 44(3):479-83.
    View in: PubMed
    Score: 0.001
  187. Toxic nephropathies. Tex Med. 1973 Jul; 69(7):60-3.
    View in: PubMed
    Score: 0.001
  188. "Over-flow ascites" - the safety valve of the volume-expanded patient on dialysis. Proc Clin Dial Transplant Forum. 1973; 3:156-61.
    View in: PubMed
    Score: 0.001
  189. Regional medical program of Texas. Kidney program. Tex Med. 1972 Dec; 69(12):79-84.
    View in: PubMed
    Score: 0.001
  190. Sodium in diets: milliequivalent, milligram? Ann Intern Med. 1972 Oct; 77(4):661-2.
    View in: PubMed
    Score: 0.001
  191. Renal morphological and immunological changes associated with acute viral hepatitis. Kidney Int. 1972 Jun; 1(6):413-9.
    View in: PubMed
    Score: 0.001
  192. Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management. J Chronic Dis. 1971 Jul; 24(4):221-7.
    View in: PubMed
    Score: 0.001
  193. Recovery from anuria due to malignant hypertension. JAMA. 1971 Feb 15; 215(7):1122-5.
    View in: PubMed
    Score: 0.001
  194. Renal diluting capacity in the hypokalemic rat. Am J Physiol. 1970 Oct; 219(4):933-7.
    View in: PubMed
    Score: 0.001
  195. Combined ascitic-fluid and furosemide infusion in the management of ascites. N Engl J Med. 1970 Mar 26; 282(13):713-7.
    View in: PubMed
    Score: 0.001
  196. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit. JAMA. 1989 Oct 20; 262(15):2108-13.
    View in: PubMed
    Score: 0.001
  197. Platelet function in renal failure. N Engl J Med. 1969 Mar 27; 280(13):677-81.
    View in: PubMed
    Score: 0.001
  198. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986 May; 65(3):163-72.
    View in: PubMed
    Score: 0.000
  199. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982 Dec 23; 307(26):1603-10.
    View in: PubMed
    Score: 0.000
  200. Effects of renal failure on leukotaxis. J Med. 1979; 10(4):267-78.
    View in: PubMed
    Score: 0.000
  201. Hypertension--a potent risk factor. Heart Lung. 1978 Jan-Feb; 7(1):137-40.
    View in: PubMed
    Score: 0.000
  202. Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone. Am J Med. 1977 Nov; 63(5):674-82.
    View in: PubMed
    Score: 0.000
  203. Human parotid saliva urea in renal failure and during dialysis. Arch Oral Biol. 1977; 22(2):83-6.
    View in: PubMed
    Score: 0.000
  204. Treatment of Goodpasture syndrome with cyclophosphamide, prednisone and plasma exchange transfusions. Clin Exp Immunol. 1976 Apr; 24(1):218-22.
    View in: PubMed
    Score: 0.000
  205. Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med. 1975 Jun; 135(6):807-10.
    View in: PubMed
    Score: 0.000
  206. Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J. 1975 Mar 08; 1(5957):550-1.
    View in: PubMed
    Score: 0.000
  207. The morphogenesis of glomerular crescents in rapidly progressive glomerulonephritis. Kidney Int. 1974 Jan; 5(1):47-56.
    View in: PubMed
    Score: 0.000
  208. Diuretics in nonedematous states. Physiological basis for the clinical use. Arch Intern Med. 1973 Jun; 131(6):797-808.
    View in: PubMed
    Score: 0.000
  209. Adult polycystic kidney disease: studies of the defect in urine concentration. Kidney Int. 1972 Aug; 2(2):107-13.
    View in: PubMed
    Score: 0.000
  210. Effects of metolazone on renal function in normal man. J Pharmacol Exp Ther. 1972 Jan; 180(1):6-12.
    View in: PubMed
    Score: 0.000
  211. Peritoneal dialysis in the treatment of renal failure in multiple myeloma. South Med J. 1971 Nov; 64(11):1403-5.
    View in: PubMed
    Score: 0.000
  212. Acute treatment of hypercalcemia with furosemide. N Engl J Med. 1970 Oct 15; 283(16):836-40.
    View in: PubMed
    Score: 0.000
  213. Hereditary nephritis in the Negro. Report of a kindred. Arch Intern Med. 1970 Mar; 125(3):451-8.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.